Literature DB >> 22323248

Imaging the inhibition by anti-β1 integrin antibody of lung seeding of single osteosarcoma cells in live mice.

Hiroaki Kimura1, Yasunori Tome, Masashi Momiyama, Katsuhiro Hayashi, Hiroyuki Tsuchiya, Michael Bouvet, Robert M Hoffman.   

Abstract

Integrins play a role in tumor growth and metastasis. However, the effect of integrin inhibition has not been visualized on single cancer cells in vivo. In this study, we used a powerful subcellular in vivo imaging model to demonstrate how an anti-integrin antibody affects seeding and growth of osteosarcoma cells on the lung. The 143B human osteosarcoma cell line, expressing red fluorescent protein (RFP) in the cytoplasm and green fluorescent protein (GFP) in the nucleus, was established. Such double-labeled cells enable imaging of apoptosis and mitosis and other nuclear-cytoplasmic dynamics. Using the double-labeled osteosarcoma cells, single cancer-cell seeding in the lung after i.v. injection of osteosarcoma cells was imaged. The anti-β1 integrin monoclonal antibody, AIIB2, greatly inhibited the seeding of cancer cells on the lung (experimental metastasis) while a control antibody had no effect. To image the efficacy of the anti-integrin antibody on spontaneous metastasis, mice with orthotopically-growing 143B-RFP cells in the tibia were also treated with AIIB2 or control anti-rat IgG1 antibody. After 3 weeks treatment, mice were sacrificed and primary tumors and lung metastases were evaluated with fluorescence imaging. AIIB2 significantly inhibited spontaneous lung metastasis but not primary tumor growth, possibly due to inhibition of lung seeding of the cancer cells as imaged in the experimental metastasis study. AIIB2 treatment also increased survival of mice with orthotopically growing 143B-RFP.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22323248     DOI: 10.1002/ijc.27475

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Far-red fluorescent cell line for preclinical study of HER2-targeted agents.

Authors:  I V Balalaeva; E A Sokolova; A A Brilkina; S M Deyev; R V Petrov
Journal:  Dokl Biochem Biophys       Date:  2016-01-05       Impact factor: 0.788

2.  Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.

Authors:  Shingo Shimozaki; Norio Yamamoto; Takahiro Domoto; Hideji Nishida; Katsuhiro Hayashi; Hiroaki Kimura; Akihiko Takeuchi; Shinji Miwa; Kentaro Igarashi; Takashi Kato; Yu Aoki; Takashi Higuchi; Mayumi Hirose; Robert M Hoffman; Toshinari Minamoto; Hiroyuki Tsuchiya
Journal:  Oncotarget       Date:  2016-11-22

3.  The disintegrin echistatin in combination with doxorubicin targets high-metastatic human osteosarcoma overexpressing ανβ3 integrin in chick embryo and nude mouse models.

Authors:  Yasunori Tome; Hiroaki Kimura; Naotoshi Sugimoto; Hiroyuki Tsuchiya; Fuminori Kanaya; Michael Bouvet; Robert M Hoffman
Journal:  Oncotarget       Date:  2016-12-27

4.  Ligand-induced Epitope Masking: DISSOCIATION OF INTEGRIN α5β1-FIBRONECTIN COMPLEXES ONLY BY MONOCLONAL ANTIBODIES WITH AN ALLOSTERIC MODE OF ACTION.

Authors:  A Paul Mould; Janet A Askari; Adam Byron; Yoshikazu Takada; Thomas A Jowitt; Martin J Humphries
Journal:  J Biol Chem       Date:  2016-08-02       Impact factor: 5.157

5.  Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma.

Authors:  Corinne Bouvier; Nicolas Macagno; Quy Nguyen; Anderson Loundou; Carine Jiguet-Jiglaire; Jean-Claude Gentet; Jean-Luc Jouve; Alexandre Rochwerger; Jean-Camille Mattei; Daniel Bouvard; Sébastien Salas
Journal:  Oncotarget       Date:  2016-10-04

6.  Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug.

Authors:  Takashi Murakami; Kentaro Igarashi; Kei Kawaguchi; Tasuku Kiyuna; Yong Zhang; Ming Zhao; Yukihiko Hiroshima; Scott D Nelson; Sarah M Dry; Yunfeng Li; Jane Yanagawa; Tara Russell; Noah Federman; Arun Singh; Irmina Elliott; Ryusei Matsuyama; Takashi Chishima; Kuniya Tanaka; Itaru Endo; Fritz C Eilber; Robert M Hoffman
Journal:  Oncotarget       Date:  2017-01-31

7.  Extracellular Collagen Mediates Osteosarcoma Progression Through an Integrin α2β1/JAK/STAT3 Signaling Pathway.

Authors:  Daiqing Wei; Cui Li; Junwu Ye; Feifan Xiang; Juncai Liu
Journal:  Cancer Manag Res       Date:  2020-11-24       Impact factor: 3.989

8.  βig-h3 promotes human osteosarcoma cells metastasis by interacting with integrin α2β1 and activating PI3K signaling pathway.

Authors:  Yun-Shan Guo; Rui Zhao; Jie Ma; Wei Cui; Zhen Sun; Bo Gao; Shu He; Yue-Hu Han; Jing Fan; Liu Yang; Juan Tang; Zhuo-Jing Luo
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

9.  Disintegrin targeting of an αvβ3 integrin-over-expressing high-metastatic human osteosarcoma with echistatin inhibits cell proliferation, migration, invasion and adhesion in vitro.

Authors:  Yasunori Tome; Hiroaki Kimura; Tasuku Kiyuna; Naotoshi Sugimoto; Hiroyuki Tsuchiya; Fuminori Kanaya; Michael Bouvet; Robert M Hoffman
Journal:  Oncotarget       Date:  2016-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.